The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome
Abstract
Bickerstaff reported eight patients who, in addition to acute ophthalmoplegia and ataxia, showed drowsiness, extensor plantar responses or hemisensory loss. This condition has been named Bickerstaff's brainstem encephalitis (BBE). One patient had gross flaccid weakness in the four limbs. Presumably because of the rarity of this disorder, there has been no reported study on a large number of patients with BBE. To clarify its clinical features, we reviewed detailed clinical profiles and laboratory findings for 62 cases of BBE diagnosed by the strict criteria of progressive, relatively symmetrical external ophthalmoplegia and ataxia by 4 weeks, and disturbance of consciousness or hyperreflexia. Ninety-two per cent of the patients involved had had an antecedent illness. Besides ophthalmoplegia and ataxia, disturbance of consciousness was frequent (74%), and facial diplegia (45%), Babinski's sign (40%) and pupillary abnormality and bulbar palsy (34%) were present. Almost all the patients had a monophasic remitting course and generally a good outcome. Serum anti-GQ1b IgG antibody was positive in 66%, and MRI showed brain abnormality in 30% of the patients. Another striking feature was the association with flaccid symmetrical tetraparesis, seen in 60% of the patients. An autopsy study of a BBE patient clearly showed the presence of definite inflammatory changes in the brainstem: there was perivascular lymphocytic infiltration with oedema and glial nodules. Electrodiagnostic study results suggested peripheral motor axonal degeneration. Limb weakness in the BBE cases studied was considered the result of overlap with the axonal subtype of Guillain-Barré syndrome. These findings confirm that BBE constitutes a clinical entity and provide additional clinical and laboratory features of BBE. A considerable number of BBE patients have associated axonal Guillain-Barré syndrome, indicative that the two disorders are closely related and form a continuous spectrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Ho, T. W., Mishu, B., Li, C. Y., Gao, C. Y., Cornblath, D. R., Griffin, J. W., Asbury, A. K., Blaser, M. J., & McKhann, G. M. (1995) · Brain · doi:10.1093/brain/118.3.597 · Cited by 764
(1997) · The Lancet · doi:10.1016/s0140-6736(96)09095-2 · Cited by 733
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80059-4 · Cited by 610
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992) · Annals of Neurology · doi:10.1002/ana.410310619 · Cited by 562
Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritis
Yuki, N., Yoshino, H., Sato, S., & Miyatake, T. (1990) · Neurology · doi:10.1212/wnl.40.12.1900 · Cited by 477
Self-citationAnti-GQ1b IgG antibody syndrome: clinical and immunological range
Odaka, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.50 · Cited by 388
Self-citationPreceding infections, immune factors, and outcome in Guillain–Barré syndrome
Hadden, R. D. M., Karch, H., Hartung, H.-P., Zielasek, J., Weissbrich, B., Schubert, J., Weishaupt, A., Cornblath, D. R., Swan, A. V., Hughes, R. A. C., et al. (2001) · Neurology · doi:10.1212/wnl.56.6.758 · Cited by 375
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Diagnosis and management of Guillain–Barré syndrome in ten steps
Leonhard, S. E., Mandarakas, M. R., Gondim, F. A. A., Bateman, K., Ferreira, M. L. B., Cornblath, D. R., van Doorn, P. A., Dourado, M. E., Hughes, R. A. C., Islam, B., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0250-9 · Cited by 910
Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P. A., & Jacobs, B. C. (2014) · Brain · doi:10.1093/brain/awt285 · Cited by 792
Guillain–Barré and Miller Fisher syndromes—new diagnostic classification
the GBS Classification Group, Wakerley, B. R., Uncini, A., & Yuki, N. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.138 · Cited by 544
Self-citationPittock, S. J., Debruyne, J., Krecke, K. N., Giannini, C., van den Ameele, J., De Herdt, V., McKeon, A., Fealey, R. D., Weinshenker, B. G., Aksamit, A. J., et al. (2010) · Brain · doi:10.1093/brain/awq164 · Cited by 371
Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome
Shahrizaila, N., & Yuki, N. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302824 · Cited by 317
Self-citationIto, M., Kuwabara, S., Odaka, M., Misawa, S., Koga, M., Hirata, K., & Yuki*, N. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0775-0 · Cited by 316
Self-citationPlatt, M. P., Agalliu, D., & Cutforth, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00442 · Cited by 108
Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist’s journey
YUKI, N. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.299 · Cited by 109
Self-citation
Metadata
- Authors
- Odaka, M., Yuki, N., Yamada, M., Koga, M., Takemi, T., Hirata, K., & Kuwabara, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-10
- Volume
- 126
- Issue
- 10
- Pages
- 2279-2290
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2166104162
- Cited by
- 440
- References
- 24
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.